Squarepoint’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-235,242
| Closed | -$710K | – | 3297 |
|
|
2025
Q1 | $710K | Buy |
235,242
+208,628
| +784% | +$630K | ﹤0.01% | 1701 |
|
|
2024
Q4 | $96.3K | Buy |
26,614
+13,233
| +99% | +$47.9K | ﹤0.01% | 2542 |
|
|
2024
Q3 | $23.6K | Buy |
+13,381
| New | +$23.6K | ﹤0.01% | 2467 |
|
|
2024
Q1 | – | Sell |
-119,450
| Closed | -$168K | – | 3020 |
|
|
2023
Q4 | $168K | Sell |
119,450
-20,540
| -15% | -$29K | ﹤0.01% | 2189 |
|
|
2023
Q3 | $221K | Sell |
139,990
-19,369
| -12% | -$30.6K | ﹤0.01% | 2070 |
|
|
2023
Q2 | $344K | Buy |
159,359
+147,185
| +1,209% | +$318K | ﹤0.01% | 1798 |
|
|
2023
Q1 | $25.6K | Buy |
+12,174
| New | +$25.6K | ﹤0.01% | 2163 |
|
|
2016
Q3 | – | Sell |
-886
| Closed | -$34K | – | 1300 |
|
|
2016
Q2 | $34K | Buy |
+886
| New | +$34K | ﹤0.01% | 1046 |
|